CDEK
← All organizations

Pasteur Merieux

For profitContributed to NME

Also known as: BioFire Diagnostics, LLC | Biofortis Mérieux NutriSciences | Mérieux NutriSciences Biofortis | Silliker, Inc. | Silliker, Inc./Plant Bioactives Research Institute

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

First clinical trial

Mar 1, 2006

First marketed drug

May 26, 1953

First NDA

May 26, 1953

Last known activity

Jun 4, 2025

Acquired by Rhone Poulenc → Rhone-Poulenc Rorer → Aventis → Sanofi-Synthelabo → Sanofi-Aventis on Jan 1, 1968

Timeline

1890s

  1. Jan 1, 1897

    Pasteur Merieux— Founded

1950s

  1. May 26, 1953

    thyrotropin— NDA Organization

1960s

  1. Jan 1, 1968

    Rhone Poulenc— Acquired By

1980s

  1. Jan 1, 1989

    Merieux Institute— Acquired

2000s

  1. Jan 1, 2004

    Sanofi-Aventis— Now

Drugs by trial phase (15 distinct, 15 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (17)

Details

Founded
Lyon, FR Jan 1, 1897
First NDA
May 26, 1953
Last known activity
Jun 4, 2025